Factors for the Growth of Pharmaceutical Expenditures Reimbursed by Public Funds: Methods and Models for Reducing Them

Veselin Tsvetkov ()
Additional contact information
Veselin Tsvetkov: University of National and World Economy, Sofia, Bulgaria

Nauchni trudove, 2008, issue 2, 277-310

Abstract: This paper discuses some of the economic factors for the growth of pharmaceutical expenditures in the end of the last and the beginning of the 21 century. It gives special attention to inequality of income allocation as a factor for implementing comprehensive health insurance coverage. It is demonstrated that this process lead to increasing of the rate of moral hazard of costumers and thus to the growth of pharmaceutical expenditures. The market failures typical for pharmaceutical market have been analyzed as additional causes for government influence. Methods and models for restricting the pharmaceutical expenditures in public sector, available in developed countries, are discussed. The measures influencing supply, demand and pure market tools are subject of special attention. As sources are used Bulgarian and International literature, periodicals, monographic issues, scientific researches and Internet stores.

Date: 2008
References: Add references at CitEc
Citations:

Downloads: (external link)
http://research.unwe.bg/uploads/ResearchPapers/Res ... No8_V%20Tsvetkov.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nwe:natrud:y:2008:i:2:p:277-310

Access Statistics for this article

More articles in Nauchni trudove from University of National and World Economy, Sofia, Bulgaria Contact information at EDIRC.
Bibliographic data for series maintained by Vanya Lazarova ().